CClinicalTrials.gg
CompletedNCT00907621Updated Mar 17, 2015Results posted

Effects of Acupuncture in the Treatment of Infant Colic

A Phase 2 interventional study of Acupuncture with Seirin 020x15 mm sterile acupuncture needle in Infant Colic, sponsored by University of Oslo. Completed at 1 site in Norway. Open to participants aged 3 Weeks to 3 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-17.

Sponsored by University of Oslo · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
3 Weeks to 3 Months
Sex
All
01

Study summary

Standardized acupuncture treatment for infant colic is a common treatment in general practice for doctors educated in medical acupuncture.

The investigators plan to study whether the perceived opinion on positive results can be verified in a multi-center clinical trial. The investigators aim to measure the effect of standardized acupuncture treatment, three repeated sessions, on infant colic in a randomized singe blinded prospective multi-center study, starting September 2009. The study will be done in thirteen locations in Norway by specialists in General Practice trained in acupuncture.

The investigators intend to include a total of 130 patients, 65 in the intervention group and 65 in the control group.

02

Conditions studied

  • Infant Colic

Browse trials for

Keywords

  • Infant Colic
  • Acupuncture
  • General Practice
03

In context

Colic

148 studies on the registry are indexed under Colic; 21 are open to participants now.

This study's enrollment of 90 is close to the median of 88 across 122 interventional studies indexed under Colic.

Browse Colic studies →

Lead sponsor

University of Oslo is the lead sponsor of 176 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Weeks to 3 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Infants under 3 months of age with birth weight over 2500 g and/or over 36th week of gestation.
  • Further fulfilling Wessel et al criteria for infant colic: "Paroxystic uncontrollable crying in an otherwise healthy child under 3 months of age, and with more than 3 hours of crying per day for more than 3 days a week for more than 3 weeks."

Exclusion criteria

Exclusion Criteria:

  • Infants over 3 months of age with birth weight under 2500 g and/or under 36th week of gestation.
  • Not fulfilling Wessel et al criteria for infant colic: "Paroxystic uncontrollable crying in an otherwise healthy child under 3 months of age, and with more than 3 hours of crying pr.day for more than 3 days a week for more than 3 weeks."
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Acupuncture

    Acupuncture with Seirin 020x15 mm sterile acupuncture needle: Bilateral insertion of a Seirin 020x15mm sterile acupuncture needle to a depth of 12mm for 30 seconds during 3 consecutive working days at the WHO designated acupuncture point St36 on infants born after 36th week of gestation and weighing over 2500 grams at birth, and who qualify according to Wessels definition: Paroxystical, uncontrolled crying in an otherwise healthy child under 3 months of age, and with more than 3 hours of crying 3 days per week for 3 weeks.

    Procedure: Acupuncture with Seirin 020x15 mm sterile acupuncture needle

  • No intervention
    Control

    Infants born after 36th week of gestation and weighing over 2500 grams at birth, and who qualify according to Wessels definition: Paroxystical, uncontrolled crying in an otherwise healthy child under 3 months of age, and with more than 3 hours of crying 3 days per week for 3 weeks. The Control group will have no intervention.

Interventions

  • ProcedureAcupuncture with Seirin 020x15 mm sterile acupuncture needle

    Bilateral insertion of a Seirin 020x15mm sterile acupuncture needle to a depth of 12mm for 30 seconds during 3 consecutive working days at the WHO designated acupuncture point St36.

    Also known as: Seirin 020x15mm sterile acupuncture needle

06

What researchers measure

Primary outcomes

  1. Change in Crying Time Per 24 Hour Period.

    Crying time per 24 hour period at baseline and post treatment

    Time frame: 6 time points measured: First, second and third intervention day, one day after last intervention, one week after last intervention and one month after last intervention. All time points measured in 24 hours.

Secondary outcomes

  1. Parents Evaluation of Benefit to the Child.

    Parents subjective assessment of the childs condition, on a 5 point scale, with 1 being worse and 5 being completely well. The numbers are the actual evaluations on the time specified.

    Time frame: 5 days, 1 , and 4 weeks after the first treatment

07

Results

Posted Mar 17, 2015
Limitations and caveats
Our choice of acupuncture points and technique could be inferior to other more potent acupuncture approaches.

Participant flow

The inclusion period was from September 2009 to December 2012.13 GP offices participated. The participating doctors were all GP specialists with a minimum of 300 hours of acupuncture education and fi ve years of practising acupuncture. The patients fulfi lled Wessel ' s criteria and were born at full term.

Participant flow — Overall Study
MilestoneAcupunctureControl
Started4545
Completed3841
Not completed74
Withdrew: Lost to follow-up63
Withdrew: Intercurrent febrile illness11

Outcome measures

PrimaryChange in Crying Time Per 24 Hour Period.

Crying time per 24 hour period at baseline and post treatment

Time frame:
6 time points measured: First, second and third intervention day, one day after last intervention, one week after last intervention and one month after last intervention. All time points measured in 24 hours.
Reported as:
Mean · minutes crying time pr 24 hour
Change in Crying Time Per 24 Hour Period.
minutes crying time pr 24 hourAcupunctureControl
Day 1 and 2-baseline220 (195 to 245)212 (183 to 241)
Day 3- 1 intervention day230 (180 to 281)186 (142 to 230)
Day 4- 2 intervention day180 (128 to 232)185 (131 to 239)
Day 5- 3 intervention day129 (97 to 162)167 (123 to 211)
Day 6- 1 day after intervention120 (94 to 145)142 (106 to 179)
Day12- 1 week after intervention121 (79 to 164)120 (91 to 149)
Day 33- 4 weeks after intervention89 (55 to 123)97 (67 to 126)
SecondaryParents Evaluation of Benefit to the Child.

Parents subjective assessment of the childs condition, on a 5 point scale, with 1 being worse and 5 being completely well. The numbers are the actual evaluations on the time specified.

Time frame:
5 days, 1 , and 4 weeks after the first treatment
Reported as:
Mean · units on a scale
Parents Evaluation of Benefit to the Child.
units on a scaleAcupunctureControl
Improvement day 52.87 ± 0.8442.78 ± 0.917
Improvement day 123.62 ± 0.8613.27 ± 0.902
Improvement day 334.03 ± 0.8853.51 ± 1.146

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Acupuncture—0/45 (0%)2/45 (4.4%)
Control—0/45 (0%)8/45 (17.8%)
Most frequent other events
Most frequent other events
EventAcupunctureControl
HickupGastrointestinal disorders1/450/45
Increased regurgitationGastrointestinal disorders1/450/45
Small HematomaGeneral disorders0/451/45
CryingGeneral disorders0/451/45
RestlessnessGeneral disorders0/451/45
Excessive stoolsGastrointestinal disorders0/451/45
Frequent defecationGastrointestinal disorders0/451/45
Light sedationGeneral disorders0/451/45
Abdominal painGastrointestinal disorders0/451/45
UneaseGeneral disorders0/451/45

Baseline characteristics

We analyzed 79 crying diaries and 84 interviews. The baseline characteristics, except crying time is based on the 84 interviews where we had complete data. The crying time is based on the 79 crying diaries

Age, Continuous
Age, Continuous(weeks)AcupunctureControlTotal
Mean6 (3 to 13)6 (3 to 9)6 (3 to 13)
Sex: Female, Male
Sex: Female, Male(Participants)AcupunctureControlTotal
Female222042
Male222042
baseline crying time in minutes
baseline crying time in minutes(crying time in minutes)AcupunctureControlTotal
Mean220 (80 to 394)212 (0 to 353)216 (0 to 394)
08

Study locations

1 site
  • Institute of Primary Care and Community Health, Faculty of Medicine, University of Oslo.
    Oslo, Norway
09

References and documents

Publications

  • Skjeie H, Skonnord T, Fetveit A, Brekke M. Acupuncture for infantile colic: a blinding-validated, randomized controlled multicentre trial in general practice. Scand J Prim Health Care. 2013 Dec;31(4):190-6. doi: 10.3109/02813432.2013.862915. Epub 2013 Nov 15. PubMed 24228748 ↗
  • Skjeie H, Skonnord T, Fetveit A, Brekke M. A pilot study of ST36 acupuncture for infantile colic. Acupunct Med. 2011 Jun;29(2):103-7. doi: 10.1136/aim.2010.003590. Epub 2011 Mar 29. PubMed 21450707 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 17, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00907621
Lead sponsor
University of Oslo
Responsible party
Arne Fetveit (Associate Professor, University of Oslo) — Principal investigator
First posted
May 22, 2009
Start date
Sep 2009
Primary completion
Dec 2012
Completion
Dec 2012
Results posted
Mar 17, 2015
Last update
Mar 17, 2015

Study contacts

Holgeir Skjeie, MD
principal investigator · Institute of Primary Care and Community Health, Faculty of Medicine, University of Oslo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion